FBC
GMED icon

Fairfield, Bush & Co’s Globus Medical GMED Stock Holding History

Fairfield, Bush & Co’s Portfolio GMED Stock Details GMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-3,750
Closed -$257K – 113
2024
Q2 		$257K Sell
3,750
-300
-7% -$17.9K 0.15% 91
2024
Q1 		$217K Sell
4,050
-140
-3% -$7.53K 0.13% 113
2023
Q4 		$223K Hold
4,190
– – 0.13% 103
2023
Q3 		$208K Hold
4,190
– – 0.14% 106
2023
Q2 		$249K Hold
4,190
– – 0.07% 136
2023
Q1 		$237K Sell
4,190
-250
-6% -$16K 0.08% 133
2022
Q4 		$330K Sell
4,440
-200
-4% -$13.6K 0.22% 91
2022
Q3 		$276K Hold
4,640
– – 0.19% 92
2022
Q2 		$260K Hold
4,640
– – 0.15% 100
2022
Q1 		$342K Sell
4,640
-1,040
-18% -$72.3K 0.17% 94
2021
Q4 		$410K Hold
5,680
– – 0.2% 84
2021
Q3 		$435K Hold
5,680
– – 0.14% 116
2021
Q2 		$440K Sell
5,680
-500
-8% -$35.5K 0.12% 115
2021
Q1 		$381K Buy
6,180
+1,900
+44% +$120K 0.11% 126
2020
Q4 		$279K Sell
4,280
-2,270
-35% -$130K 0.08% 130
2020
Q3 		$324K Buy
+6,550
New +$338K 0.1% 116

Other funds holding GMED

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BAM
Burgundy Asset Management Toronto, Ontario, Canada $10.6B AUM 13.39% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
SC
Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return
HRCM
Hawk Ridge Capital Management Los Angeles, California $2.75B AUM 20.09% 1-Year Est. Return

Fairfield, Bush & Co's GMED Position: Q3 2024 in Review

Fairfield, Bush & Co sold out of Globus Medical (GMED) in Q3 2024, closing a stake of 3,750 shares — an estimated $257K sold.

Fairfield, Bush & Co first reported a position in GMED in Q3 2020 and held it in 16 quarters. The position peaked at $440K in Q2 2021. 449 funds tracked by Wall St. Rank hold GMED as of Q3 2024.

  • Fairfield, Bush & Co reported no remaining Globus Medical position as of Q3 2024 after selling out during the quarter.
  • Fairfield, Bush & Co sold 3,750 Globus Medical shares in Q3 2024, an estimated $257K.
  • Fairfield, Bush & Co first reported a position in Globus Medical in Q3 2020 and held it in 16 quarters.
  • Fairfield, Bush & Co's Globus Medical position peaked at $440K in Q2 2021.
  • 449 funds tracked by Wall St. Rank held Globus Medical as of Q3 2024.

Based on Fairfield, Bush & Co's 13F filing for Q3 2024, filed 12 Nov 2024.